š„ A DCO license isnāt a bureaucratic badge ā itās the gateway that lets a crypto exchange clear its own futures, cutting friction and pulling institutional capital.
š Geminiās Olympus unit just secured a CFTCāapproved Derivatives Clearing Organization license, unlocking ināhouse clearing for its products. #Gemini #CFTC
š” This regulatory win cements crypto derivatives as a mainstream asset class, syncing with todayās greedādriven market (70/100) and an overbought Bitcoin rally, hinting at another wave of institutional inflow. #CryptoDerivatives #Institutional
š° With BTC futures open interest at $9.58āÆB, funding positive at +0.0091%, and top traders net long 69.1%, the clearing advantage can tighten spreads and lower counterparty risk; combine that with Bitcoin at $85,713 (+6.48%) and Ethereum at $2,736 (+6.09%) while smart money floods Solana wallets (e.g., AWARDED +4,492% inflow), a modest allocation to exchangeācleared contracts becomes a tactical hedge.
ā How will you adjust your exposure now that a major player can clear its own contractsāmore direct futures, stay on spot, or wait for the next regulatory win?
š Geminiās Olympus unit just secured a CFTCāapproved Derivatives Clearing Organization license, unlocking ināhouse clearing for its products. #Gemini #CFTC
š” This regulatory win cements crypto derivatives as a mainstream asset class, syncing with todayās greedādriven market (70/100) and an overbought Bitcoin rally, hinting at another wave of institutional inflow. #CryptoDerivatives #Institutional
š° With BTC futures open interest at $9.58āÆB, funding positive at +0.0091%, and top traders net long 69.1%, the clearing advantage can tighten spreads and lower counterparty risk; combine that with Bitcoin at $85,713 (+6.48%) and Ethereum at $2,736 (+6.09%) while smart money floods Solana wallets (e.g., AWARDED +4,492% inflow), a modest allocation to exchangeācleared contracts becomes a tactical hedge.
ā How will you adjust your exposure now that a major player can clear its own contractsāmore direct futures, stay on spot, or wait for the next regulatory win?
